ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,20%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,1303
0,00%
Bitcoin
65.424,20
0,28%
Brent Oil
83,155
-0,06%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) Notícias

QTRX

Quanterix (QTRX)

Quanterix Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:QTRX
DataHoraFonteTítuloCódigoCompanhia
16/05/202417:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
08/05/202415:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTRXQuanterix Corporation
07/05/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
07/05/202417:00Business WireQuanterix Releases Financial Results for the First Quarter of 2024NASDAQ:QTRXQuanterix Corporation
29/04/202417:00Business WireQuanterix To Report First Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
21/03/202418:30Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing InfrastructureNASDAQ:QTRXQuanterix Corporation
04/03/202419:27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTRXQuanterix Corporation
04/03/202411:00Business WireQuanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
29/02/202418:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QTRXQuanterix Corporation
29/02/202418:00Business WireQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023NASDAQ:QTRXQuanterix Corporation
26/02/202420:58Business WireQuanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceNASDAQ:QTRXQuanterix Corporation
26/02/202411:00Business WireQuanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
23/02/202418:30Business WireQuanterix to Present at Cowen’s 44th Annual Health Care ConferenceNASDAQ:QTRXQuanterix Corporation
16/02/202418:00Business WireQuanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallNASDAQ:QTRXQuanterix Corporation
14/02/202418:57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
02/01/202419:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QTRXQuanterix Corporation
12/12/202318:00Business WireQuanterix to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
13/11/202318:00Business WireQuanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:QTRXQuanterix Corporation
13/11/202309:00GlobeNewswire Inc.Sotera Health Appoints Karen Flynn to Board of DirectorsNASDAQ:QTRXQuanterix Corporation
06/11/202319:56Business WireQuanterix Releases Operating Results for Third Quarter 2023NASDAQ:QTRXQuanterix Corporation
06/11/202318:50Business WireQuanterix Releases Operating Results for Third Quarter 202NASDAQ:QTRXQuanterix Corporation
30/10/202317:00Business WireQuanterix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:QTRXQuanterix Corporation
24/10/202317:30Business WireQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
23/10/202321:30Business WireQuanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease DetectionNASDAQ:QTRXQuanterix Corporation
28/09/202318:00Business WireQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease DayNASDAQ:QTRXQuanterix Corporation
05/09/202309:00Business WireQuanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
22/08/202318:02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
21/08/202317:30Business WireWilliam P. Donnelly Appointed to Quanterix’s Board of DirectorsNASDAQ:QTRXQuanterix Corporation
09/08/202309:30Business WireQuanterix Appoints Vandana Sriram as Chief Financial OfficerNASDAQ:QTRXQuanterix Corporation
07/08/202318:13Business WireQuanterix Releases Operating Results for Second Quarter 2023NASDAQ:QTRXQuanterix Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:QTRX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HBOR3
HELBOR ON
BOV
BRSR6
BANRISUL PNB
BOV
GFSA3
GAFISA ON
BOV
PRIO3
PETRORIO ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados